首页> 美国卫生研究院文献>PLoS Clinical Trials >Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

【2h】

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

机译：无创肝储备标志物在肝癌经动脉化疗栓塞患者中的预后作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundVarious noninvasive liver reserve markers were proposed to indicate the severity of liver damage. However, the role and feasibility of these markers to predict the prognosis of patients with hepatocellular carcinoma (HCC) are unknown. We aimed to identify the prognostic role of the 8 currently used hepatic reserve markers in patients with HCC undergoing transarterial chemoembolization (TACE).

机译：背景技术提出了各种非侵入性肝脏储备标志物来指示肝损害的严重程度。然而，这些标记物在预测肝细胞癌（HCC）患者预后中的作用和可行性尚不明确。我们旨在确定目前使用的8种肝储备标志物在进行肝动脉化疗栓塞（TACE）的HCC患者中的预后作用。

著录项

期刊名称 PLoS Clinical Trials
作者
Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Cheng-Yuan Hsia; Yun-Hsuan Lee; Rheun-Chuan Lee; Yi-Hsiang Huang; Fa-Yauh Lee; Ming-Chih Hou; Ya-Ju Tsai; Teh-Ia Huo;
展开▼
作者单位

展开▼
年(卷),期 2011(12),7
年度 2011
页码 e0180408
总页数 13
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization [J] . A. Rebonato, L. Graziosi, D. Maiettini, Gastroenterology research and practice . 2017,第Pta2期

机译：炎症标志物作为肝细胞癌患者患者存活的预后因素
2. Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization [J] . A. Rebonato, L. Graziosi, D. Maiettini, Gastroenterology research and practice . 2017,第Pta1期

机译：炎症标志物作为肝细胞癌患者患者存活的预后因素
3. Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma [J] . Kang Woo-Hyoung, Hwang Shin, Song Gi-Won, Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society . 2017,第6期

机译：经动化疗栓塞诱导的肝切除患者完全病理反应的预后作用及肝细胞癌移植
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization [O] . A. Rebonato, L. Graziosi, D. Maiettini, 2017

机译：炎症标志物作为经肝动脉化疗栓塞治疗的肝细胞癌患者生存的预后因素
7. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. [O] . Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, 2017

机译：非侵袭性肝储备标志物在经肝动脉化疗栓塞的肝细胞癌患者中的预后作用。

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

摘要

著录项

相似文献

相关主题

期刊订阅